The life of a patent is 17 years in the United States.
At the time of the light bulb's invention, the term of protection on a patent was 17 years.
The drug will not be able to be patented again. Once the patent runs out, other companies can manufacture it without paying licensing rights.
In the US, drug patents give twenty years of protection, but they are applied for before clinical trials begin, so the effective life of a drug patent tends to be between seven and twelve years.
Copyright and patent protection is for a limited time, but trademarks can be protected for as long as they are in use.
Patents have nothing to do with the FDA. The 17 year life is given by the US Patent office and dictates how long a drug can be marketed exclusively and without a generic competitor. The 17-year clock starts ticking when the patent is filed which is very early in the development cycle. As the time to approval of a drug is around 10-12 years, the company has only 5-7 years to recoup the enormous investment (close to $1b) costs involved with bringing that drug to market.
The patent expires in 2017. You don't have all that long to wait.
I believe that with any drug, the company that did all the research and development (usually 10 or so years) to make the drug wants to recoup their investment. Thus they have a patent for a lengthy period of time so that only that one company can manufacture the drug. Once the patent expires then one of two things happens: they can revise the drug and get another patent, or release the drug so that any company can make it. Since all the research and development is already done, those companies can make it much cheaper - they just can't make or market it by its original name (in this case Viagra) - it has to be marketed under its generic name. When you see the symbol "R" enclosed in a circle after the name, that is an indication that is the original trade name. Generics do not have that symbol.
When a pharmaceutical company patents a new medicine, it gets to keep the sole right of sale for a period of time (I think it's 5 years, but may be wrong), in order to allow the company to recoup its research expenditures and have some incentive to perform more R&D. After that time, and in order to make the med available to areas with limited economies, the patent expires, and drug is released in generic form. The original inventor can of course still market the drug. ---- Under the current system, a new pharmaceutical product is under patent protection for 20 years from invention. While this seems a long period, one must understand it can take 8 to 10 years or more for clinical trials to be performed and enough data to be collected to pass through FDA approval. This leaves the company inventing the new drug with however much time is left in their patent to sell it, without competition. After this patent period has passed, other companies may produce the drug and market it. With more companies producing the drugs, the prices generally come down.
US patents are for 20 years, so a 1992 patent expired on its issue date in 2012.
A "pending patent" does not exist. A patent application which is pending at the patent office is typically referred to as "patent pending", but has not yet matured into an enforceable right. A patent application can, in theory, be pending indefinitely as long as you are willing to pay to keep it alive (via Requests for Continued Examination or via continuation applications, and so forth).
2012.
The patent date should be just in from of the bolt under the rear sight. But only if it is a bolt action!!!!